APPLICATION
ANDA074746
TYPE
ANDA
ORIGINAL APPROVAL
1997-03-25
LATEST ACTION
2020-04-03
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
TIMOLOL MALEATEPrescription
TIMOLOL MALEATE EQ 0.25% BASE · SOLUTION/DROPS · OPHTHALMIC
Approval history
2020-04-03Labeling · Supplement 16 · standardAP
2015-10-06Labeling · Supplement 12 · standardAP
2005-04-08Labeling · Supplement 10AP
2003-07-14Labeling · Supplement 8AP
2002-11-15Manufacturing (CMC) · Supplement 7AP
2002-07-03Manufacturing (CMC) · Supplement 6AP
2002-01-08Manufacturing (CMC) · Supplement 5AP
2001-08-15Manufacturing (CMC) · Supplement 4AP
2000-12-08Manufacturing (CMC) · Supplement 3AP
2000-03-29Labeling · Supplement 2AP
1997-12-16Manufacturing (CMC) · Supplement 1AP
1997-03-25OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.